Filing Analysis

📄 Other SEC Filing Filed Jun 09, 2026
⚪ LOW

Exagen Inc. reported the final voting results from its 2026 annual meeting of stockholders held on June 9, 2026. Stockholders elected two Class I directors, ratified the appointment of BDO USA, P.C. as the independent auditor, and approved executive compensation.

📋 Key Facts

  • Election of Class I directors Tina S. Nova, Ph.D. and Scott Kahn, Ph.D. for three-year terms expiring in 2029.
  • Ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
  • Advisory approval of named executive officer compensation.
  • Significant broker non-votes were present in Proposal 1 (approx 17.3M total) and Proposal 3 (approx 8.6M).
📢 Regulation FD Disclosure Filed May 11, 2026
⚪ LOW

Exagen Inc. reported its financial results for the first quarter ended March 31, 2026. The results were disclosed via a press release furnished as an exhibit to the filing.

📋 Key Facts

  • Financial results reported for the three months ended March 31, 2026
  • Filing date and report date are both May 11, 2026
  • Information was furnished under Item 2.02 (Results of Operations and Financial Condition)
  • The report was signed by Jeffrey G. Black, Chief Financial Officer
🚪 Officer Departure Filed Apr 23, 2026
⚪ LOW

On April 17, 2026, Ana Hooker resigned from Exagen Inc.'s Board of Directors and its committees. The company subsequently reduced its board size from eight to seven members and reconstituted its standing committees.

📋 Key Facts

  • Ana Hooker resigned as a director effective April 17, 2026.
  • Ms. Hooker served as the chair of the Nominating and Corporate Governance Committee and was a member of the Audit Committee.
  • The resignation was not due to any disagreement with the company's operations, policies, or practices.
  • The Board of Directors' size was reduced from eight to seven members following the resignation.
  • The company announced the new composition of the Audit, Compensation, and Nominating and Corporate Governance committees.
📢 Regulation FD Disclosure Filed Mar 10, 2026
⚪ LOW

Exagen Inc. reported its financial results for the fourth quarter and fiscal year ended December 31, 2025, via a press release furnished with the SEC.

📋 Key Facts

  • Financial results for Q4 and FY 2025 reported on March 10, 2026
  • Information furnished under Item 2.02 (Results of Operations and Financial Condition)
  • Exhibit 99.1 contains the full press release
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for XGN

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial